Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Financial Services FeesIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest Expense - DebtInterest Expense - DepositsInterest Expense - Fed FundsInterest ExpensesInterest Income - Fed FundsInterest Income - NetInterest Income - TotalNet Income towards Common StockholdersNon-Interest IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Non-Interest IncomeOther Operating ExpensesOther interest incomeProfit After TaxProvisionsResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Joint Stock Co Kaspi.kz (KSPI) Research & Development: 2023-2025

Historic Research & Development for Joint Stock Co Kaspi.kz (KSPI) over the last 3 years, with Sep 2025 value amounting to -$151.8 billion.

  • Joint Stock Co Kaspi.kz's Research & Development fell 451.38% to -$151.8 billion in Q3 2025 from the same period last year, while for Sep 2025 it was -$317.9 billion, marking a year-over-year decrease of 192.18%. This contributed to the annual value of -$109.6 billion for FY2024, which is 23.57% down from last year.
  • Joint Stock Co Kaspi.kz's Research & Development amounted to -$151.8 billion in Q3 2025, which was down 61.90% from -$93.8 billion recorded in Q2 2025.
  • In the past 5 years, Joint Stock Co Kaspi.kz's Research & Development ranged from a high of -$18.0 billion in Q1 2023 and a low of -$151.8 billion during Q3 2025.
  • Moreover, its 3-year median value for Research & Development was -$27.5 billion (2024), whereas its average is -$44.2 billion.
  • Data for Joint Stock Co Kaspi.kz's Research & Development shows a maximum YoY plummeted of 451.38% (in 2025) over the last 5 years.
  • Quarterly analysis of 3 years shows Joint Stock Co Kaspi.kz's Research & Development stood at -$28.6 billion in 2023, then dropped by 2.67% to -$29.3 billion in 2024, then plummeted by 451.38% to -$151.8 billion in 2025.
  • Its Research & Development stands at -$151.8 billion for Q3 2025, versus -$93.8 billion for Q2 2025 and -$42.9 billion for Q1 2025.